Finance

Lists
NRC:NASDAQ
NRC Health
$20.57
-3.79%
(-0.81) 1D
Aug 12, 1:40:10โ€ฏPM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NRC...
Open
$21.16
High
$21.39
Low
$19.79
Mkt. cap
455.00M
Avg. vol.
99.56K
Volume
59.63K
Dividend
3.11%
Quarterly dividend
$0.16
Ex-dividend date
Sep 25, 2026
P/E ratio
81.48
52-wk high
$23.68
52-wk low
$11.01
EPS
$0.25
Beta
0.34
Shares outstanding
22.12M
No. of employees
357
Open
$21.16
High
$21.39
Low
$19.79
Mkt. cap
455.00M
Avg. vol.
99.56K
Volume
59.63K
Dividend
3.11%
Quarterly dividend
$0.16
Ex-dividend date
Sep 25, 2026
P/E ratio
81.48
52-wk high
$23.68
52-wk low
$11.01
EPS
$0.25
Beta
0.34
Shares outstanding
22.12M
No. of employees
357
News stories
From web sources and news partners
Profile
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska. Wikipedia
About NRC Health
CEOMichael Hays
Employees357
Founded1981
HeadquartersLincoln, Nebraska, United States
SectorHealth care provider
Websitenrchealth.com
Analyst ratings
Based on 1 analyst giving stock ratings to NRC in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for NRC in the last 3 months
Highest
Current $20.57
$26.00 (+26.40%)
Average
$26.00 (+26.40%)
Lowest
$26.00 (+26.40%)
Analyst
Recommendation
Action
Price target
Projected
Date
Constantine Davides
Citizens JMP
Buy
Maintained
$26.00
+26.4%
07/29/2026
Last report
Jul 28, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.31 / $0.14
+121.43%beat
Revenue / Est. (USD)
35.39M / 34.90M
+1.41%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
34.61M
35.19M
34.80M
35.39M
Cost of goods sold
12.40M
13.94M
13.65M
13.56M
Cost of revenue
12.40M
13.94M
13.65M
13.56M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.27M
7.79M
13.42M
19.78M
Operating expense
14.47M
9.94M
15.59M
21.91M
Total operating expenses
26.87M
23.87M
29.23M
35.47M
Operating income
7.74M
11.32M
5.57M
-78.00K
Other non operating income
-45.00K
-61.00K
30.00K
2.00K
EBT including unusual items
6.27M
3.27M
4.38M
-4.54M
EBT excluding unusual items
6.27M
9.92M
4.38M
-1.38M
Income tax expense
2.15M
1.47M
1.16M
-1.25M
Effective tax rate
34.29%
45.00%
26.42%
27.64%
Other operating expenses
-
-
-
-
Net income
4.12M
1.80M
3.22M
-3.28M
Net profit margin
11.91%
5.11%
9.26%
-9.28%
Earnings per share
-
-
-
0.31
Interest and investment income
41.00K
29.00K
35.00K
20.00K
Interest expense
-1.46M
-1.37M
-1.26M
-1.32M
Net interest expenses
-1.42M
-1.34M
-1.22M
-1.30M
Depreciation and amortization charges
2.20M
2.14M
2.17M
2.12M
EBITDA
9.93M
13.47M
7.74M
2.04M
Gain or loss from assets sale
-
61.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore whatโ€™s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps